David A. Ramsay
2011
Compensation breakdown
Non-Equity Incentive Plan | $56,252 |
---|---|
Option Awards | $80,057 |
Salary | $253,351 |
Stock Awards | $62,531 |
Other | $7,712 |
Total | $459,903 |
Ramsay received $253.4K in salary, accounting for 55% of the total pay in 2011.
Ramsay also received $56.3K in non-equity incentive plan, $80.1K in option awards, $62.5K in stock awards and $7.7K in other compensation.
Rankings
In 2011, David A. Ramsay's compensation ranked 8,313th out of 10,747 executives tracked by ExecPay. In other words, Ramsay earned more than 22.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,313 | 23rd |
Manufacturing | 3,059 | 23rd |
Chemicals And Allied Products | 767 | 26th |
Drugs | 554 | 30th |
Biological Products, Except Diagnostic Substances | 95 | 41st |
Ramsay's colleagues
We found six more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
Gregory Frost
Halozyme Therapeutics